Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cécile Tonnelle

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medecine Sciences : M/S|January 1, 2009
[Ikaros and erythropoiesis]Marilyne Dijon, Christian Chabannon, Cécile Tonnelle
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cellsThomas Moreau, Florence Bardin, Jean Imbert, et al.
Leukemia & Lymphoma|March 23, 2002
Ikaros gene expression and leukemiaCécile Tonnelle, Boris Calmels, Christine Maroc, et al.
Blood|October 16, 2007
The role of Ikaros in human erythroid differentiationMarilyne Dijon, Florence Bardin, Anne Murati, et al.
Current Gene Therapy|November 1, 2007
Potential application of gene therapy to X-linked agammaglobulinemiaThomas Moreau, Boris Calmels, Vincent Barlogis, et al.
Molecular Immunology|March 17, 2009
Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiationCécile Tonnelle, Marilyne Dijon, Thomas Moreau, et al.
Cytotherapy|February 25, 2009
Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID miceThomas Moreau, Florence Bardin, Vincent Barlogis, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 17, 2003
Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigenCécile Tonnelle, Marie-Christine Imbert, Danielle Sainty, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medecine Sciences : M/S|January 1, 2009
[Ikaros and erythropoiesis]Marilyne Dijon, Christian Chabannon, Cécile Tonnelle
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cellsThomas Moreau, Florence Bardin, Jean Imbert, et al.
Leukemia & Lymphoma|March 23, 2002
Ikaros gene expression and leukemiaCécile Tonnelle, Boris Calmels, Christine Maroc, et al.
Blood|October 16, 2007
The role of Ikaros in human erythroid differentiationMarilyne Dijon, Florence Bardin, Anne Murati, et al.
Current Gene Therapy|November 1, 2007
Potential application of gene therapy to X-linked agammaglobulinemiaThomas Moreau, Boris Calmels, Vincent Barlogis, et al.
Molecular Immunology|March 17, 2009
Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiationCécile Tonnelle, Marilyne Dijon, Thomas Moreau, et al.
Cytotherapy|February 25, 2009
Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID miceThomas Moreau, Florence Bardin, Vincent Barlogis, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 17, 2003
Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigenCécile Tonnelle, Marie-Christine Imbert, Danielle Sainty, et al.
Pageof 1